[EN] N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3-(TRIFLUOROMETHYL)PHENYL)OXAZOLE-2-CARBOXAMIDE DERIVATIVES AND THE CORRESPONDING OXADIAZOLE DERIVATIVES AS USP30 INHIBITORS FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION<br/>[FR] N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3- (TRIFLUOROMÉTHYL)PHÉNYL)OXAZOLE-2-CARBOXAMIDE ET DÉRIVÉS D'OXADIAZOLE CORRESPONDANTS UTILISÉS EN TANT QU'INHIBITEURS D'USP30 POUR LE TRAITEMENT D'UN DYSFONCTIONNEMENT MITOCHONDRIAL
申请人:MISSION THERAPEUTICS LTD
公开号:WO2021239863A1
公开(公告)日:2021-12-02
The present invention relates to a class of N-cyanopyrrolidines with activity as inhibitors of the deubiquitylating enzyme USP30, having utility in a variety of therapeutic areas, including conditions involving mitochondrial dysfunction, cancer and fibrosis: Formula (I), Formula (II)..
本发明涉及一类具有作为去泛素化酶USP30抑制剂活性的N-氰基吡咯烷衍生物,可用于包括涉及线粒体功能障碍、癌症和纤维化等多种治疗领域:公式(I),公式(II)..